Managing IBD in 2010
This regional inflammatory bowel disease (IBD) meeting, Managing IBD in 2010: evidence, experience and commitment, is an international scientific meeting with a world-class faculty who will review current treatment options and explore future developments for patients with IBD.
Discussions will include information on traditional and novel treatment options for ulcerative colitis and Crohn’s disease and the role of IBD in colorectal cancer (CRC) development and whether some IBD therapies can help to prevent CRC. In addition, insights into the latest endoscopy technology will be shared.
This exclusive event will be an opportunity for a select group of professionals to exchange views on topics including:
- Difference between Eastern and Western Europeans in IBD prevalence
- Similarities and differences in IBD across Central and Eastern Europe
- The rising incidence of childhood IBD and the resulting consequences for management
- The hygiene hypothesis in IBD
- The role of 5ASA as an essential treatment for all patients with UC
- ECCO versus government guidelines on biologics in UC
- How to treat severe colitis
- The future of UC treatment
- Risks of malignancy associated with novel IBD treatments
- Cancer surveillance in IBD
- Treatment approaches to prevent dysplasia and cancer
- Detection of dysplasia
- Importance of good bowel cleansing
- The role of mucosal healing
- Considering clinical situations and impact on treatment decisions with endoscopy
- Innovation of new high-tech endoscopy
- Patient adherence to pharmacological treatment
- Advances in personalised medicine
- The place of 5ASA in mild CD
- The role of biologics and surgery in CD
- Perianal disease
Committee Chairmen
Professor Severine Vermeire (Belgium)
Professor Laszlo Lakatos (Hungary)
Date
16th - 17th April 2010
Location
Hotel InterContinental
Budapest, Hungary
